These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 7914520)
21. Elafin is a potent inhibitor of proteinase 3. Wiedow O; Lüademann J; Utecht B Biochem Biophys Res Commun; 1991 Jan; 174(1):6-10. PubMed ID: 1989620 [TBL] [Abstract][Full Text] [Related]
22. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. Sallenave JM; Marsden MD; Ryle AP Biol Chem Hoppe Seyler; 1992 Jan; 373(1):27-33. PubMed ID: 1536690 [TBL] [Abstract][Full Text] [Related]
23. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241 [TBL] [Abstract][Full Text] [Related]
24. The gene of the protease inhibitor SKALP/elafin is a member of the REST gene family. Lundwall A; Ulvsback M Biochem Biophys Res Commun; 1996 Apr; 221(2):323-7. PubMed ID: 8619854 [TBL] [Abstract][Full Text] [Related]
25. Accelerated evolution in inhibitor domains of porcine elafin family members. Tamechika I; Itakura M; Saruta Y; Furukawa M; Kato A; Tachibana S; Hirose S J Biol Chem; 1996 Mar; 271(12):7012-8. PubMed ID: 8636131 [TBL] [Abstract][Full Text] [Related]
26. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris. Zani ML; Nobar SM; Lacour SA; Lemoine S; Boudier C; Bieth JG; Moreau T Eur J Biochem; 2004 Jun; 271(12):2370-8. PubMed ID: 15182352 [TBL] [Abstract][Full Text] [Related]
27. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin. Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702 [TBL] [Abstract][Full Text] [Related]
29. The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Schalkwijk J; Wiedow O; Hirose S Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):569-77. PubMed ID: 10359639 [TBL] [Abstract][Full Text] [Related]
30. Cryptic origin of SPAI, a plasma protein with a transglutaminase substrate domain and the WAP motif, revealed by in situ hybridization and immunohistochemistry. Furukawa M; Suzuki Y; Ghoneim MA; Tachibana S; Hirose S J Biol Chem; 1996 Nov; 271(47):29517-20. PubMed ID: 8939875 [TBL] [Abstract][Full Text] [Related]
31. Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa. Bellemare A; Vernoux N; Morin S; Gagné SM; Bourbonnais Y BMC Microbiol; 2010 Oct; 10():253. PubMed ID: 20932308 [TBL] [Abstract][Full Text] [Related]
32. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung. Tremblay GM; Sallenave JM; Israél-Assayag E; Cormier Y; Gauldie J Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1092-8. PubMed ID: 8887613 [TBL] [Abstract][Full Text] [Related]
33. Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase. Mehul B; Bawumia S; Hughes RC FEBS Lett; 1995 Feb; 360(2):160-4. PubMed ID: 7875321 [TBL] [Abstract][Full Text] [Related]
34. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Jensen PH; Lorand L; Ebbesen P; Gliemann J Eur J Biochem; 1993 May; 214(1):141-6. PubMed ID: 8099547 [TBL] [Abstract][Full Text] [Related]
35. Discovery of a new type of proteinase inhibitor family whose members have an anchoring sequence. Hirose S; Furukawa M; Tamechika I; Itakura M; Kato A; Suzuki Y; Kuroki J; Tachibana S Adv Exp Med Biol; 1996; 389():43-9. PubMed ID: 8860992 [No Abstract] [Full Text] [Related]
36. Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitor. Tsunemi M; Kato H; Nishiuchi Y; Kumagaye S; Sakakibara S Biochem Biophys Res Commun; 1992 Jun; 185(3):967-73. PubMed ID: 1627147 [TBL] [Abstract][Full Text] [Related]
37. Characterization of human pre-elafin mutants: full antipeptidase activity is essential to preserve lung tissue integrity in experimental emphysema. Doucet A; Bouchard D; Janelle MF; Bellemare A; Gagné S; Tremblay GM; Bourbonnais Y Biochem J; 2007 Aug; 405(3):455-63. PubMed ID: 17489739 [TBL] [Abstract][Full Text] [Related]
38. alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study. Hevessy Z; Patthy A; Kárpáti L; Muszbek L Thromb Res; 2000 Aug; 99(4):399-406. PubMed ID: 10963790 [No Abstract] [Full Text] [Related]
39. Mapping the heparin-binding site of mucus proteinase inhibitor. Mellet P; Ermolieff J; Bieth JG Biochemistry; 1995 Feb; 34(8):2645-52. PubMed ID: 7873546 [TBL] [Abstract][Full Text] [Related]
40. Cross-linking of elafin/SKALP to elastic fibers in photodamaged skin: too much of a good thing? Schalkwijk J J Invest Dermatol; 2007 Jun; 127(6):1286-7. PubMed ID: 17502858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]